Profile
SILO VRTX REGN VRNA ARGX ALNY
Company Name Silo Pharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $2.43M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Eric Weisblum Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SILO VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
SILO VRTX REGN VRNA ARGX ALNY
Last Close $0.4085 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.98 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.41 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -79.37 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low -0.37 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SILO VRTX REGN VRNA ARGX ALNY
1 Month Return -27.03 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -42.16 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -15.48 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -70.82 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -54.1 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -57.88 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SILO VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1599497.67 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
SILO VRTX REGN VRNA ARGX ALNY
Asset Growth -4.32 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year -47.84 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year -59.33 % 73.64 % - 775.72 %
Revenue 10 Year 117.53 % 285.02 % - 2487.4 %
EBIT Growth -21 % 9.09 % -131.37 % 24.59 %
Net Income Growth -18.7 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -158.01 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 0.78 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -203.76 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -22.05 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -18.9 % - -143.33 % -107.98 %
Operating 3 Year CFG 13.24 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -10.46 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 6.09 % -100 % 40.15 % 97.08 %
EPS Growth 0.83 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 0.83 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -31.8 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -71.36 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 5132.95 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -44.67 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share -100 % - - -
Debt Growth - 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -18.9 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SILO VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM -806.41 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -79.52 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -107.04 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -94.63 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 94.52 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -7449.72 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 1.03 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 1.13 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.51 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.51 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 63.64 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -6655.15 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.51 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -0.59 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -0.59 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
SILO VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 91.9% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.19 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
SILO VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.01B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
SILO VRTX REGN VRNA ARGX ALNY
Net Income $-0B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.2
AARD Aardvark Therapeutics, Inc. Common Stock 12.28
ABCL AbCellera Biologics Inc. 2.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.39
ABPWW 0.0131
ABSI Absci Corporation 2.42
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.54
ACAD ACADIA Pharmaceuticals Inc. 21.61
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.72
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ETFs With Exposure to SILO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.00137 57.76
VT Vanguard Total World Stock Index Fund 0.00032 145.96
EIDO iShares MSCI Indonesia ETF 0.11 17.89
VXUS Vanguard Total Intl Stock Idx Fund 0.00039 82.13
VSS Vanguard FTSE All-World ex-US Small Capital Index Fund 0.00431 156.39
VXF Vanguard Extended Market Index Fund 0 213.85
VSGX Vanguard ESG International Stock ETF 0.00013 77.91
AVEM Avantis Emerging Markets Equity ETF 0 85.95
EMIM.L iShares Core MSCI EM IMI UCITS ETF 0 3665
VTSNX Vanguard Total Intl Stock Idx Fund 0.00039 176.43
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 162.32
IEMS.L iShares MSCI EM Small Cap UCITS ETF USD (Dist) 0.02 110.19
IMIB.MI iShares FTSE MIB UCITS ETF EUR (Dist) 0 28.035
ISFE.L iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist) 0.03 3277.5
AVES Avantis Emerging Markets Value ETF 0 64.6
EIMI.L iShares Public Limited Company - iShares Core MSCI EM IMI UCITS ETF 0 49.94
IS3N.DE iShares Core MSCI EM IMI UCITS ETF 0.00194 42.103
VFSAX Vanguard FTSE All-World ex-US Small-Cap Index Fund Admiral Shares 0.00431 38.41
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 162.33
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.00137 47.91
V3AB.L Vanguard Funds Public Limited Company - Vanguard ESG Global All Cap UCITS ETF 0.00102 5.84
EUNI.DE iShares MSCI EM Small Cap UCITS ETF USD (Dist) 0.03258 92.55
V3AM.L Vanguard ESG Global All Cap UCITS ETF 0.00102 5.434
V3AA.L Vanguard Funds Public Limited Company - Vanguard ESG Global All Cap UCITS ETF 0.00102 7.9305
V3AL.L Vanguard Funds Public Limited Company - Vanguard ESG Global All Cap UCITS ETF 0.00102 7.406
IMIB.L iShares II Public Limited Company - iShares FTSE MIB UCITS ETF EUR (Dist) 0 2442
VTIAX Vanguard Total International Stock Index Fd Admiral 0.00039 44.12
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0.00032 51.65
PSIL AdvisorShares Psychedelics ETF 1.04 16.108
VGE.AX Vanguard FTSE Emerging Markets Shares ETF 0.00136 89.97
VEMPX Vanguard Extended Market Index InstlPlus 0 400.57
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.00137 121.18
AVXC Avantis Emerging Markets ex-China Equity ETF 0.02 72.3579
VTWIX Vanguard Total World Stock Index I 0.00032 297.78
VTPSX Vanguard Total Intl Stock Idx InstlPls 0.00039 176.47
Unlock